Black Rose Industries Ltd (BLACKROSE)
🎯 Key Takeaways
- Black Rose Industries Ltd is transitioning from a distribution-focused chemical trader to a higher-margin manufacturing player with growing export traction and product diversification. The company demonstrated strong operational momentum in FY26, reporting 38% revenue growth and 90% EBITDA growth, supported by capacity expansion and improved utilization.
- Revenue declined 14.4% QoQ to ₹89 in Q1FY27.
- ⚠️ Overreliance on export recovery and global demand conditions poses downside risk to growth momentum.
- Market Cap
- ₹574
- P/E Ratio
- 20.0
- P/B Ratio
- 3.39
- ROE
- 16.9%
- ROCE
- 23.4%
- Debt/Equity
- 0.01
- Div Yield
- 1.11%
- Promoter
- 75.0%
📖 The Story
Black Rose Industries Ltd is transitioning from a distribution-focused chemical trader to a higher-margin manufacturing player with growing export traction and product diversification. The company demonstrated strong operational momentum in FY26, reporting 38% revenue growth and 90% EBITDA growth, supported by capacity expansion and improved utilization. It maintains a debt-free balance sheet and a disciplined capital allocation approach, returning 125% dividends while reinvesting in downstream integration. Management expects sustained margin improvement and demand recovery in Q1 FY27, driven by new product commercialization and export order strength.
📰 What's Happening
In its FY26 results filing dated 2026-03-31, management highlighted 38% YoY revenue growth and 90% EBITDA growth, driven by volume gains in manufacturing and distribution efficiency. The company declared a 125% dividend and emphasized capacity expansion in acrylamide products, new product development, and export recovery. Key developments include improved manufacturing capacity utilization and the commercialization of a PAM solid project during FY27. Management also noted the transition from distribution to higher-margin manufacturing as a strategic shift, with new downstream products expected to contribute to top-line growth.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 84 | 75 | 104 | 89 |
| Operating Profit | 6 | 6 | 12 | 13 |
| OPM % | 7.5% | 7.4% | 11.5% | 14.9% |
| Net Profit | 4 | 4 | 9 | 10 |
| EPS | ₹0.87 | ₹0.86 | ₹1.85 | ₹2.04 |
The company's financial performance shows a clear upward trajectory in profitability and operational efficiency. Revenue grew from ₹75 crore in Dec 2025 to ₹89 crore in Jun 2026, while operating profit margin expanded from 7.4% to 14.9% over the same period. Net profit and EPS have risen consistently, from ₹4 crore and ₹0.86 in Dec 2025 to ₹10 crore and ₹2.04 in Jun 2026. This margin expansion aligns with management's focus on higher-margin manufacturing and improved capacity utilization, indicating successful execution of its operational transformation.
🔮 Management Outlook & What's Next
Management expects demand recovery in Q1 FY27, supported by export order strength and commercialization of the PAM solid project. It anticipates sustained margin improvement and top-line growth driven by new downstream products and continued export recovery. While avoiding specific EBITDA targets due to market volatility, management expressed confidence in the durability of margins and the scalability of its manufacturing model, citing multiple growth drivers including product diversification and global market access.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 |
| Reserves | 148 | 136 | 164 | 150 |
| Borrowings | 11 | 17 | 1 | 8 |
| Total Liabilities | 214 | 190 | 208 | 213 |
| Fixed Assets | 43 | 40 | 44 | 41 |
| Investments | 0 | 0 | 20 | 10 |
| Total Assets | 214 | 190 | 208 | 213 |
The balance sheet reflects a strong and stable financial position with minimal leverage and consistent asset growth. Total assets increased slightly to ₹208 crore as of Mar 2026, while equity and reserves remained stable at ₹5 crore and ₹164 crore respectively. Borrowings have declined from ₹11 crore to ₹1 crore over the past year, indicating successful deleveraging. The company maintains a debt-free status and a robust equity base, supporting its expansion plans without financial strain, and reinforcing its capacity to fund growth internally.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | -13 |
| Investing | +12 |
| Financing | -8 |
| Net Cash Flow | -9 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 75.0% | 75.0% | 75.0% | 75.0% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 0.1% | 0.1% | 0.1% | 0.2% |
| Public | 18.8% | 18.7% | 18.7% | 18.7% |
| # Shareholders | 52,795 | 51,517 | 50,206 | 50,231 |
Shareholding patterns show stable promoter holding at 75% over the last five quarters, with a gradual decline in retail public participation from 18.84% to 18.67% and a slight rise in institutional investor presence from 0.07% to 0.18% in DII. However, FII holdings remain negligible at 0%. The growing number of shareholders (50,231) suggests increasing retail interest, but the lack of FII investment may reflect limited visibility or sectoral underweighting. No significant changes in promoter pledging or selling activity are evident.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.50 L Cr | 56.5 | 33.4% | — | 0.01 |
| SRF | 72,171 | 33.4 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,799 | 96.6 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,503 | 79.3 | 9.6% | — | 0.34 |
| NAVINFLUOR | 42,232 | 53.4 | 22.2% | — | 0.31 |
| GODREJIND | 35,513 | 30.2 | 9.2% | — | 4.57 |
| HSCL | 33,663 | 41.8 | 20.7% | — | 0.16 |
| AETHER | 23,246 | 98.6 | 13.8% | — | 0.08 |
| DEEPAKNTR | 20,783 | 26.5 | 15.3% | — | 0.26 |
| CASTROLIND | 19,792 | 18.6 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Overreliance on export recovery and global demand conditions poses downside risk to growth momentum. 2. Execution risk in scaling new product lines and downstream integration could pressure margins if commercialization falters. 3. Pricing pressure in the chemical sector may limit margin expansion despite volume gains. 4. Low institutional investor interest may affect liquidity and market depth, potentially leading to higher volatility.
📋 Recent Filings
- Announcement2026-09-29Black Rose Industries Ltd announced the closure of its trading window for insider dealing effective 1 October 2026 until the declaration of quarterly …
- 🟡 voting results2026-09-10Black Rose Industries reported unanimous passage of all four AGM resolutions via remote e-voting and in-person voting on September 9, 2026. Shareholde…
- 🟡 Board Meeting2026-09-09At the 36th AGM on 9 September 2026, shareholders approved the audited standalone and consolidated financial statements for FY2026, declared a final d…
- 🟡 concall transcript2026-03-31Black Rose Industries reported FY26 revenue growth of 38% and EBITDA growth of 90% driven by manufacturing expansion and distribution volume gains, de…
🧠 Analyst's Read
Black Rose Industries is executing a clear strategic shift toward higher-margin manufacturing with improving operational efficiency and export traction. Investors should monitor execution of new product commercialization and export order inflows in the upcoming quarters to assess the sustainability of growth and margins.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when BLACKROSE files new disclosures
Track BLACKROSE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track BLACKROSE — FreeFree account · 2 AI queries/day